Fonteneau JF - Search Results

1

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.

Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, Dunbar PR, Cerundolo V, Julkunen I, Nixon DF, Bhardwaj N. Larsson M, et al. Among authors: fonteneau jf. J Immunol. 2000 Aug 1;165(3):1182-90. doi: 10.4049/jimmunol.165.3.1182. J Immunol. 2000. PMID: 10903715

2

Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.

Labarriere N, Diez E, Pandolfino MC, Viret C, Guilloux Y, Le Guiner S, Fonteneau JF, Dreno B, Jotereau F. Labarriere N, et al. Among authors: fonteneau jf. J Immunol. 1997 Feb 1;158(3):1238-45. J Immunol. 1997. PMID: 9013965

3

Heterogeneity of biologic responses of melanoma-specific CTL.

Fonteneau JF, Le Dréan E, Le Guiner S, Gervois N, Diez E, Jotereau F. Fonteneau JF, et al. J Immunol. 1997 Sep 15;159(6):2831-9. J Immunol. 1997. PMID: 9300706

4

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Valmori D, Fonteneau JF, Lizana CM, Gervois N, Liénard D, Rimoldi D, Jongeneel V, Jotereau F, Cerottini JC, Romero P. Valmori D, et al. Among authors: fonteneau jf. J Immunol. 1998 Feb 15;160(4):1750-8. J Immunol. 1998. PMID: 9469433

5

Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.

Valmori D, Gervois N, Rimoldi D, Fonteneau JF, Bonelo A, Liénard D, Rivoltini L, Jotereau F, Cerottini JC, Romero P. Valmori D, et al. Among authors: fonteneau jf. J Immunol. 1998 Dec 15;161(12):6956-62. J Immunol. 1998. PMID: 9862730

6

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Valmori D, Fonteneau JF, Valitutti S, Gervois N, Dunbar R, Liénard D, Rimoldi D, Cerundolo V, Jotereau F, Cerottini JC, Speiser DE, Romero P. Valmori D, et al. Among authors: fonteneau jf. Int Immunol. 1999 Dec;11(12):1971-80. doi: 10.1093/intimm/11.12.1971. Int Immunol. 1999. PMID: 10590263

7

EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

Bickham K, Münz C, Tsang ML, Larsson M, Fonteneau JF, Bhardwaj N, Steinman R. Bickham K, et al. Among authors: fonteneau jf. J Clin Invest. 2001 Jan;107(1):121-30. doi: 10.1172/JCI10209. J Clin Invest. 2001. PMID: 11134187 Free PMC article.

8

Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.

Dhodapkar MV, Young JW, Chapman PB, Cox WI, Fonteneau JF, Amigorena S, Houghton AN, Steinman RM, Bhardwaj N. Dhodapkar MV, et al. Among authors: fonteneau jf. Clin Cancer Res. 2000 Dec;6(12):4831-8. Clin Cancer Res. 2000. PMID: 11156242

9

Dendritic cells resurrect antigens from dead cells.

Larsson M, Fonteneau JF, Bhardwaj N. Larsson M, et al. Among authors: fonteneau jf. Trends Immunol. 2001 Mar;22(3):141-8. doi: 10.1016/s1471-4906(01)01860-9. Trends Immunol. 2001. PMID: 11286729 Review.

10

Dendritic cell-dead cell interactions: implications and relevance for immunotherapy.

Fonteneau JF, Larsson M, Bhardwaj N. Fonteneau JF, et al. J Immunother. 2001 Jul-Aug;24(4):294-304. doi: 10.1097/00002371-200107000-00005. J Immunother. 2001. PMID: 11565831 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters